Intco Medical Technology (300677.SZ) plans to spend 80-120 million yuan to repurchase shares.
Yingke Medical (300677.SZ) announcement, the company plans to use its own funds to repurchase a portion through centralized bidding...
Intco Medical Technology (300677.SZ) announced that the company plans to use its own funds to repurchase some of its company shares through centralized bidding trading (RMB ordinary shares (A shares)) for the implementation of an employee stock ownership plan and/or equity incentive. The total amount of repurchase funds will not be less than RMB 80 million (inclusive) and not more than RMB 120 million (inclusive), with a repurchase price limit of RMB 26.66 per share (inclusive).
Related Articles
Q TECH (01478) intends to sell 51% stake of its Indian subsidiary to Dixon, India for a total consideration of 5.53 billion Rupees.
JL Mag Rare-Earth (06680) announces profit growth expectation in the first half of the year, with a net profit attributable to shareholders of 3 billion to 3.35 billion yuan, a year-on-year increase of 151%-180%.
ACESO LIFE SCI (00474) is selling a total of 569 million shares of Huatian International Construction Investment.
Q TECH (01478) intends to sell 51% stake of its Indian subsidiary to Dixon, India for a total consideration of 5.53 billion Rupees.
JL Mag Rare-Earth (06680) announces profit growth expectation in the first half of the year, with a net profit attributable to shareholders of 3 billion to 3.35 billion yuan, a year-on-year increase of 151%-180%.
ACESO LIFE SCI (00474) is selling a total of 569 million shares of Huatian International Construction Investment.
RECOMMEND
Jensen Huang Confirms NVIDIA to Begin H20 Chip Shipments to China
15/07/2025
Manus Exits China Market Amid $500 Million Valuation, Prompting Concerns Over AI Agent Sector Outlook
15/07/2025
Trump to Allocate $70 Billion in AI and Energy Investment, Escalating the Race for Technological Dominance
15/07/2025
